Foulon M - Search Results

1

Purification and Characterization of Extracellular Vesicles from Mycobacterium ulcerans Culture.

Foulon M, Marion E, Marsollier L. Foulon M, et al. Methods Mol Biol. 2022;2387:41-51. doi: 10.1007/978-1-0716-1779-3_5. Methods Mol Biol. 2022. PMID: 34643900

2

Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection.

Foulon M, Pouchin A, Manry J, Khater F, Robbe-Saule M, Durand A, Esnault L, Delneste Y, Jeannin P, Saint-André JP, Croué A, Altare F, Abel L, Alcaïs A, Marion E. Foulon M, et al. Sci Adv. 2020 Feb 26;6(9):eaax7781. doi: 10.1126/sciadv.aax7781. eCollection 2020 Feb. Sci Adv. 2020. PMID: 32133396 Free PMC article.

3

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology.

Foulon M, Robbe-Saule M, Manry J, Esnault L, Boucaud Y, Alcaïs A, Malloci M, Fanton d'Andon M, Beauvais T, Labarriere N, Jeannin P, Abel L, Saint-André JP, Croué A, Delneste Y, Boneca IG, Marsollier L, Marion E. Foulon M, et al. PLoS Pathog. 2020 Dec 18;16(12):e1009107. doi: 10.1371/journal.ppat.1009107. eCollection 2020 Dec. PLoS Pathog. 2020. PMID: 33338061 Free PMC article.

4

Ketogenic Diet Impairment of Mycobacterium ulcerans Growth and Toxin Production and Enhancement of Host Response to Infection in an Experimental Mouse Model.

Foulon M, Robbe-Saule M, Esnault L, Malloci M, Mery A, Saint-André JP, Croue A, Kempf M, Homedan C, Marion E, Marsollier L. Foulon M, et al. J Infect Dis. 2021 Dec 1;224(11):1973-1983. doi: 10.1093/infdis/jiab236. J Infect Dis. 2021. PMID: 33944942

5

Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: New insights into the regulation of mycolactone.

Robbe-Saule M, Foulon M, Poncin I, Esnault L, Varet H, Legendre R, Besnard A, Grzegorzewicz AE, Jackson M, Canaan S, Marsollier L, Marion E. Robbe-Saule M, et al. Among authors: foulon m. Virulence. 2021 Dec;12(1):1438-1451. doi: 10.1080/21505594.2021.1929749. Virulence. 2021. PMID: 34107844 Free PMC article.

6

Computed tomographic airway morphology after targeted lung denervation treatment in COPD.

Hartman JE, Herth FJF, Shah P, Pison C, Valipour A, Slebos DJ; AIRFLOW-2 Study Group. Hartman JE, et al. Respir Med. 2023 Jan;206:107059. doi: 10.1016/j.rmed.2022.107059. Epub 2022 Nov 26. Respir Med. 2023. PMID: 36459953 Free article. Clinical Trial.

7

Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.

Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.

8

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.

Slebos DJ, Shah PL, Herth FJF, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Srikanthan K, Duller M, Valipour A; AIRFLOW-2 Study Group. Slebos DJ, et al. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1477-1486. doi: 10.1164/rccm.201903-0624OC. Am J Respir Crit Care Med. 2019. PMID: 31404499 Free PMC article. Clinical Trial.

9

Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge.

Crouzet L, Derrien M, Cherbuy C, Plancade S, Foulon M, Chalin B, van Hylckama Vlieg JET, Grompone G, Rigottier-Gois L, Serror P. Crouzet L, et al. Among authors: foulon m. Sci Rep. 2018 Mar 23;8(1):5098. doi: 10.1038/s41598-018-23437-9. Sci Rep. 2018. PMID: 29572473 Free PMC article.

10

Crystal structure of tris-[4-(di-methyl-amino)-pyridinium] tris-(oxalato-κ(2) O,O')chromate(III) tetra-hydrate.

Makon Ma Houga N, Capet F, Nenwa J, Bebga G, Foulon M. Makon Ma Houga N, et al. Among authors: foulon m. Acta Crystallogr E Crystallogr Commun. 2015 Oct 31;71(Pt 11):1408-10. doi: 10.1107/S2056989015020113. eCollection 2015 Nov 1. Acta Crystallogr E Crystallogr Commun. 2015. PMID: 26594521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page